Triple-negative breast cancer (TNBC) is associated with a poor prognosis and the absence of targeted therapy. c-Kit, a receptor tyrosine kinase (RTK), is considered a molecular target for anticancer drugs. Tyrosine kinase inhibitors (TKIs) recognizing c-Kit are used for the treatment of c-Kit-expressing tumors. However, the expression, function, and therapeutic potential of c-Kit have been little explored in TNBC. Here, we studied the expression and effects of c-Kit in TNBC through in vitro and in silico analysis, and evaluated the response to TKIs targeting c-Kit. Analysis of TNBC cells showed the expression of functional c-Kit at the cell membrane. The stimulation of c-Kit with its ligand induced the activation of STAT3, Akt, and ERK1/2, increasing cell migration, but had no effect on cell proliferation or response to Doxorubicin. Analysis of public datasets showed that the expression of c-Kit in tumors was not associated with patient survival. Finally, TNBC cells were susceptible to TKIs, in particular the effect of Nilotinib was stronger than Doxorubicin in all cell lines. In conclusion, TNBC cells express functional c-Kit, which is a targetable molecule, and show a strong response to Nilotinib that may be considered a candidate drug for the treatment of TNBC.
3 October 2026 in Journal of Surgical Case Reports
Situs ambiguus, or heterotaxy, is a rare disorder of organ lateralization often accompanied by intestinal malrotation and an increased risk of midgut volvulus. Most published cases involve children with major cardiac disease, and adult presentation is exceptional. We describe a previously healthy 27-year-old woman who came to the emergency department with acute abdominal pain, peritonitis, leukocytosis, and elevated lactate. Contrast-enhanced computed tomography showed the mesenteric whirl sign, a midline liver, polysplenia, and a small splenic artery aneurysm. At laparotomy we found a 180° mesenteric torsion with vascular compromise but no necrosis, and after manual detorsion we opted for a planned second-look laparotomy at 24 h rather than resection. The second look confirmed bowel recovery, and she was discharged on day 12 without complications. A staged surgical approach can help preserve bowel in adults with aberrant mesenteric anatomy when viability is uncertain at the first operation.